The investigation provides a potential strategy to enhance chemotherapeutic efficacy by blocking the EV miRNA-OC-2 axis, but the role of OC-2 in breast cancer development and gene therapy has not been clarified. The gene discussed is ONECUT2; the disease is breast cancer.